Watson Pharmaceuticals has received FDA approval for Next Choice, a generic version of Duramed Pharmaceuticals‘ Plan B (levonorgestrel tablets) for over-the-counter use in women ≥17 years of age. Next Choice received FDA approval on June 24, 2009 for use in postpubertal women <17 years of age by prescription only.
Next Choice is indicated for the prevention of pregnancy after known or suspected contraceptive failure or unprotected intercourse. Next Choice is already available by prescription and is expected to be available over-the-counter soon.
For more information call (800) 272-5525 or visit www.watson.com.